| scholarly article | Q13442814 |
| P50 | author | Ivet Bahar | Q21262533 |
| P2093 | author name string | Ji Young Lee | |
| Hongchun Li | |||
| James M Krieger | |||
| P2860 | cites work | Computer-Aided Drug Design Methods. | Q51311450 |
| SuperStar: a knowledge-based approach for identifying interaction sites in proteins. | Q52211818 | ||
| Machine learning in chemoinformatics and drug discovery. | Q54373716 | ||
| CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. | Q55518828 | ||
| Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors | Q58571868 | ||
| Analysis of tractable allosteric sites in G protein-coupled receptors | Q64110733 | ||
| Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors | Q64233687 | ||
| Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents. | Q64992482 | ||
| MixMD Probeview: Robust Binding Site Prediction from Cosolvent Simulations | Q89112638 | ||
| Free Energies and Entropies of Binding Sites Identified by MixMD Cosolvent Simulations | Q90267981 | ||
| Druggability Simulations and X-Ray Crystallography Reveal a Ligand-Binding Site in the GluA3 AMPA Receptor N-Terminal Domain | Q90353407 | ||
| All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening | Q90619451 | ||
| Mechanisms of postsynaptic localization of AMPA-type glutamate receptors and their regulation during long-term potentiation | Q90842847 | ||
| Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator | Q24338252 | ||
| Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe Molecules | Q24633124 | ||
| Functional insights from glutamate receptor ion channel structures | Q26994781 | ||
| Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core | Q27628494 | ||
| Mechanism of glutamate receptor desensitization | Q27639007 | ||
| Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites | Q27649098 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 | ||
| Scalable molecular dynamics with NAMD | Q27860718 | ||
| Glutamate receptor ion channels: structure, regulation, and function | Q28290774 | ||
| Inhibition of Peroxidase Activity of Cytochrome c: De Novo Compound Discovery and Validation | Q28386865 | ||
| Computational fragment-based binding site identification by ligand competitive saturation | Q28475699 | ||
| Structure-based druggability assessment of the mammalian structural proteome with inclusion of light protein flexibility | Q28541379 | ||
| The ChEMBL database in 2017 | Q28584450 | ||
| ZINC 15--Ligand Discovery for Everyone | Q28607096 | ||
| Pharmit: interactive exploration of chemical space | Q28830087 | ||
| Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations | Q29547631 | ||
| CHARMM additive and polarizable force fields for biophysics and computer-aided drug design | Q30365988 | ||
| Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery. | Q30372876 | ||
| A computational procedure for determining energetically favorable binding sites on biologically important macromolecules | Q30406755 | ||
| Binding site detection and druggability prediction of protein targets for structure-based drug design | Q30422561 | ||
| Protein-protein interface analysis and hot spots identification for chemical ligand design | Q30431131 | ||
| Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents | Q30457615 | ||
| LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters | Q31143138 | ||
| Hot-spots-guided receptor-based pharmacophores (HS-Pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores | Q33345491 | ||
| Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets | Q33556394 | ||
| ProDy: protein dynamics inferred from theory and experiments | Q33864431 | ||
| Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors | Q33953050 | ||
| Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach | Q34054370 | ||
| Evol and ProDy for bridging protein sequence evolution and structural dynamics | Q34136883 | ||
| Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor | Q34571210 | ||
| PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results | Q34584338 | ||
| X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism | Q34679478 | ||
| Binding site detection and druggability index from first principles. | Q34964806 | ||
| Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach | Q35045753 | ||
| AMPA receptor potentiators: from drug design to cognitive enhancement | Q35054673 | ||
| Structure-based virtual screening for drug discovery: principles, applications and recent advances. | Q35282223 | ||
| Binding hotspots on K-ras: consensus ligand binding sites and other reactive regions from probe-based molecular dynamics analysis | Q35450396 | ||
| ZINCPharmer: pharmacophore search of the ZINC database | Q36088378 | ||
| Identifying binding hot spots on protein surfaces by mixed-solvent molecular dynamics: HIV-1 protease as a test case | Q36218072 | ||
| Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery | Q36269125 | ||
| iGNM 2.0: the Gaussian network model database for biomolecular structural dynamics | Q36434861 | ||
| PharmaGist: a webserver for ligand-based pharmacophore detection | Q36749332 | ||
| Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise | Q37053828 | ||
| Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model | Q37395726 | ||
| Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems | Q37558652 | ||
| Three-dimensional pharmacophore methods in drug discovery | Q37615315 | ||
| Pharmacophore modeling and applications in drug discovery: challenges and recent advances | Q37723606 | ||
| Motions of Allosteric and Orthosteric Ligand-Binding Sites in Proteins are Highly Correlated | Q39436125 | ||
| Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death | Q39592538 | ||
| Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling | Q40412571 | ||
| Channel opening and gating mechanism in AMPA-subtype glutamate receptors | Q41597083 | ||
| Structural Bases of Desensitization in AMPA Receptor-Auxiliary Subunit Complexes | Q41598077 | ||
| Identification of common functional configurations among molecules | Q42633535 | ||
| N-substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulators. | Q42849473 | ||
| Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. | Q42907951 | ||
| Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules. | Q43161207 | ||
| Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
| Allosteric Modulation of Intact γ-Secretase Structural Dynamics | Q47270654 | ||
| Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking | Q47669698 | ||
| Activation and Desensitization Mechanism of AMPA Receptor-TARP Complex by Cryo-EM. | Q47930517 | ||
| 7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency | Q48095397 | ||
| GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition. | Q48453010 | ||
| Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's. | Q50736206 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 76-86 | |
| P577 | publication date | 2019-12-04 | |
| P1433 | published in | Protein Science | Q7251445 |
| P1476 | title | Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations | |
| P478 | volume | 29 |
Search more.